Who we are

We are committed to providing women new choices improving their daily life

Inspired by Women

For over twenty years, Mithra has dedicated its researches so as to redefine women’s health by bringing innovative products in the fields of contraception and menopause.

Today, Mithra counts two complementary platforms: its portfolio of innovative products based on Estetrol (E4) and its portfolio of Complex Therapeutics. The whole supported by the Mithra CDMO, a technological platform offering a wide range of services going from pharmaceutical development to commercial manufacturing.

Biotech
founded in

1999

Listed
Euronext

2015

Market
countries

100

Passionate
people

350

We develop innovative products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span

What we do

Since the launch of the first generic contraceptive pill in Belgium, Mithra always focused on innovation for women.

After years of research and development, our pipeline today includes late-stage development products, potential blockbusters and complex therapeutics in the fields of contraception and menopause. These projects are powered by our Mithra CDMO, our unique R&D and manufacturing platform.

Over 20 years of women’s health

Mithra has always been defined by its science and its innovation. Along the years, our mission always remains the same: innovate to serve women.

Today we’re closer than ever to revolutionizing the field of women’s health in both contraception and menopause.

Prof. Dr. Jean-Michel Foidart

Co-founder

From the spin-off born at the University of Liège to a listed biotech with over 350 collaborators, our co-founder, François Fornieri, shares the story behind Mithra’s success.